Betta Pharmaceuticals Co., Ltd. (SHE:300558)
China · Delayed Price · Currency is CNY 50.48
-0.07 (-0.14%)
Aug 31, 2026, 3:04 PM CST
Betta Pharmaceuticals Market Cap
Betta Pharmaceuticals has a market cap or net worth of 21.27 billion as of August 31, 2026. Its market cap has decreased by -28.47% in one year.
Market Cap
21.27B
Enterprise Value
23.29B
Revenue
3.85B
Ranking
n/a
PE Ratio
45.31
Stock Price
50.48
ChartMarket Cap Chart
Since November 7, 2016, Betta Pharmaceuticals's market cap has increased from 10.15B to 21.27B, an increase of 109.63%. That is a compound annual growth rate of 7.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 31, 2026 | 21.27B | 8.27% |
| Dec 31, 2025 | 19.64B | -12.96% |
| Dec 31, 2024 | 22.57B | 4.62% |
| Dec 29, 2023 | 21.57B | 5.11% |
| Dec 30, 2022 | 20.53B | -38.09% |
| Dec 31, 2021 | 33.15B | -25.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 7, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hubei Jumpcan Pharmaceutical | 23.09B |
| Walvax Biotechnology | 22.84B |
| Harbin Pharmaceutical Group | 22.67B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 22.39B |
| Tasly Pharmaceutical Group | 22.24B |
| Guangdong Zhongsheng Pharmaceutical | 21.97B |
| Jilin Aodong Pharmaceutical Group | 21.83B |
| Livzon Pharmaceutical Group | 20.96B |